HARMONY MEDICAL DISTRIBUTION LIMITED

Company Registration Number:
02096638 (England and Wales)

Unaudited abridged accounts for the year ended 30 April 2024

Period of accounts

Start date: 01 May 2023

End date: 30 April 2024

HARMONY MEDICAL DISTRIBUTION LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2024

Balance sheet
Notes

HARMONY MEDICAL DISTRIBUTION LIMITED

Balance sheet

As at 30 April 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 525,000 525,000
Tangible assets: 4 56,507 67,058
Investments: 5 100 100
Total fixed assets: 581,607 592,158
Current assets
Stocks: 436,500 200,634
Debtors:   1,021,506 728,031
Cash at bank and in hand: 300,504 449,638
Total current assets: 1,758,510 1,378,303
Creditors: amounts falling due within one year:   (843,945) (658,059)
Net current assets (liabilities): 914,565 720,244
Total assets less current liabilities: 1,496,172 1,312,402
Total net assets (liabilities): 1,496,172 1,312,402
Capital and reserves
Called up share capital: 10 10
Profit and loss account: 1,496,162 1,312,392
Shareholders funds: 1,496,172 1,312,402

The notes form part of these financial statements

HARMONY MEDICAL DISTRIBUTION LIMITED

Balance sheet statements

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 25 November 2024
and signed on behalf of the board by:

Name: Jim Belcher
Status: Director

The notes form part of these financial statements

HARMONY MEDICAL DISTRIBUTION LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HARMONY MEDICAL DISTRIBUTION LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

2. Employees

2024 2023
Average number of employees during the period 3 3

HARMONY MEDICAL DISTRIBUTION LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

3. Intangible Assets

Total
Cost £
At 01 May 2023 525,000
At 30 April 2024 525,000
Amortisation
At 01 May 2023 0
At 30 April 2024 0
Net book value
At 30 April 2024 525,000
At 30 April 2023 525,000

HARMONY MEDICAL DISTRIBUTION LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

4. Tangible Assets

Total
Cost £
At 01 May 2023 88,754
Additions 9,000
At 30 April 2024 97,754
Depreciation
At 01 May 2023 21,696
Charge for year 19,551
At 30 April 2024 41,247
Net book value
At 30 April 2024 56,507
At 30 April 2023 67,058

HARMONY MEDICAL DISTRIBUTION LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

5. Fixed investments

Fixed asset investment is the shareholding in the subsidiary.